Syntax Research, Inc.
- SEC CIK
- 0001999827
- Latest filing
- Jul 31, 2026
CVS holding history
CVS Health Corp in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 203
- Value
- $21.0K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 203 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 203 | $14.6K | <0.1% | −168−45.3% | Reduced | Holders |
| Q4 2025 | 371 | $29.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 371 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 371 | $25.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 371 | $25.1K | <0.1% | −401−51.9% | Reduced | Holders |
| Q4 2024 | 772 | $34.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 772 | $48.5K | <0.1% | −155−16.7% | Reduced | Holders |
| Q2 2024 | 927 | $54.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 927 | $73.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 927 | $73.2K | 0.1% | −12−1.3% | Reduced | Holders |
| Q3 2023 | 939 | $65.6K | 0.1% | – | No prior filing | Holders |